100 likes | 290 Views
Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also been witnessing the growing awareness of orphan drugs. However, the high cost of drug development could pose a challenge to the growth of this market. The Global Orphan Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Orphan Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space are Novartis AG, F. Hoffmann-La Roche Ltd., Celgene Corp., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report are Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Biogen Idec Inc., Bristol-Myers-Squibb Co., GlaxoSmithKline plc, Eli Lilly
E N D
Global Orphan Drugs Market 2014-2018 Published Date: January 2014 Number of Pages: 66 Price: Single User: US$2500 Corporate User: US$3500
New Market Research Report on “Global Orphan Drugs Market 2014-2018” added to ReportsnReports.com Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also been witnessing the growing awareness of orphan drugs. However, the high cost of drug development could pose a challenge to the growth of this market.
Global Orphan Drugs Market 2014-2018 The Global Orphan Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Orphan Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space are Novartis AG, F. Hoffmann-La Roche Ltd., Celgene Corp., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report are Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Biogen Idec Inc., Bristol-Myers-Squibb Co., GlaxoSmithKline plc, Eli Lilly & Co., Merck KGaA, Novo Nordisk A/S, Onyx Pharmaceuticals Inc., Shire plc, and Vertex Pharmaceuticals Inc. Request Discount on the report is available at http://www.reportsnreports.com/contacts/discount.aspx?name=274574 .
Global Orphan Drugs Market 2014-2018 Key questions answered in this report: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Buy the report @ http://www.reportsnreports.com/purchase.aspx?name=274574 .
Global Orphan Drugs Market 2014-2018 Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report03.1 Market Overview03.2 Product Offerings 04. Market Research Methodology04.1 Market Research Process04.2 Research Methodology 05. Introduction Browse more research reports on Pharmaceuticals @ http://www.reportsnreports.com/market-research/pharmaceuticals/ .
Global Orphan Drugs Market 2014-2018 Table of Contents 06. Market Landscape06.1 Market Overview06.2 Market Size and Forecast06.3 Global Biologics Orphan Drugs MarketMarket Size and Forecast06.4 Global Non-Biologic Orphan Drugs MarketMarket Size and Forecast06.5 Five Forces Analysis Request Discount on the report is available at http://www.reportsnreports.com/contacts/discount.aspx?name=274574 .
Global Orphan Drugs Market 2014-2018 Table of Contents 07. Market Segmentation by Product 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape16.1 Competitive Scenario16.1.1 Key News16.1.2 Mergers and Acquisitions16.2 Market Share Analysis 201216.3 Other Prominent Vendors Buy the report @ http://www.reportsnreports.com/purchase.aspx?name=274574 .
Global Orphan Drugs Market 2014-2018 Table of Contents 17. Key Vendor Analysis17.1 Novartis AG17.1.1 Business Overview17.1.2 Business Segmentation17.1.3 Key Information17.1.4 SWOT Analysis17.2 F. Hoffmann La Roche Ltd.17.2.1 Business Overview17.2.2 Business Segmentation17.2.3 Key Information17.2.4 SWOT Analysis17.3 Celgene Corp.17.3.1 Business Overview Browse more research reports on Pharmaceuticals @ http://www.reportsnreports.com/market-research/pharmaceuticals/ .
Global Orphan Drugs Market 2014-2018 Table of Contents 17. Key Vendor Analysis17.3.2 Key Information17.3.3 SWOT Analysis17.4 Pfizer Inc.17.4.1 Business Overview17.4.2 Key Information17.4.3 SWOT Analysis17.5 Sanofi S.A.17.5.1 Business Overview17.5.2 Business Segmentation17.5.3 Key Information17.5.4 SWOT Analysis Request Discount on the report is available at http://www.reportsnreports.com/contacts/discount.aspx?name=274574 .
About ReportsnReports ReportsnReports.com is your single source for all market research needs. Our database includes 250,000+ syndicated market research reports from 100+ leading global publishers covering in-depth analysis of over 5000 micro markets. With comprehensive information about the publishers and their report methodology, data sources, etc. we help you in your purchase decision by mapping your information needs with the most relevant available reports in our library. Connect with us: sales@reportsandreports.com + 1 888 391 5441 Contact: sales@reportsandreports.com for further information. Contact: sales@reportsandreports.com for further information.